* Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, Illinois 60611; The National
Center for Microscopy and Imaging Research at San Diego, University of California, La Jolla, California 92093; and § Cold
Spring Harbor Laboratory, Cold Spring Harbor, New York 11724
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The perinucleolar compartment (PNC) is a unique nuclear structure localized at the periphery of the nucleolus. Several small RNAs transcribed by RNA polymerase III and two hnRNP proteins have been localized in the PNC (Ghetti, A., S. Piñol-Roma, W.M. Michael, C. Morandi, and G. Dreyfuss. 1992. Nucleic Acids Res. 20:3671-3678; Matera, A.G., M.R. Frey, K. Margelot, and S.L. Wolin. 1995. J. Cell Biol. 129:1181- 1193; Timchenko, L.T., J.W. Miller, N.A. Timchenko, D.R. DeVore, K.V. Datar, L. Lin, R. Roberts, C.T. Caskey, and M.S. Swanson. 1996. Nucleic Acids Res. 24: 4407-4414; Huang, S., T. Deerinck, M.H. Ellisman, and D.L. Spector. 1997. J. Cell Biol. 137:965-974). In this report, we show that the PNC incorporates Br-UTP and FITC-conjugated CTP within 5 min of pulse labeling. Selective inhibition of RNA polymerase I does not appreciably affect the nucleotide incorporation in the PNC. Inhibition of all RNA polymerases by actinomycin D blocks the incorporation completely, suggesting that Br-UTP incorporation in the PNC is due to transcription by RNA polymerases II and/or III. Treatment of cells with an RNA polymerase II and III inhibitor induces a significant reorganization of the PNC. In addition, double labeling experiments showed that poly(A) RNA and some of the factors required for pre-mRNA processing were localized in the PNC in addition to being distributed in their previously characterized nucleoplasmic domains. Fluorescence recovery after photobleaching (FRAP) analysis revealed a rapid turnover of polypyrimidine tract binding protein within the PNC, demonstrating the dynamic nature of the structure. Together, these findings suggest that the PNC is a functional compartment involved in RNA metabolism in the cell nucleus.
Key words: perinucleolar compartment; nucleolus, nuclear body; nuclear structure; transcription ![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE perinucleolar compartment (PNC)1 was first described by the localization of the heterogeneous nuclear ribonucleoprotein I/polypyrimidine tract binding protein (hnRNP I/PTB) (Ghetti et al., 1992). This
subnuclear compartment is an irregularly shaped structure
with a large variability in size ranging from 0.25 to 1 µm in
diameter, and it is localized at the periphery of the nucleolus. The PNC is predominantly found in transformed cells and rarely observed in normal primary cells (Huang et al.,
1997
). Cell cycle analysis using immunolabeling showed
that the PNC dissociates at the beginning of mitosis and
reforms at late telophase in the daughter nuclei. Time-lapse observations of living cells transiently expressing
green fluorescent protein-tagged PTB (GFP-PTB) revealed that the PNC is a dynamic structure exhibiting discrete movements over time (Huang et al., 1997
). Electron
microscopic examination of optimally fixed HeLa cells
demonstrated that the PNC is composed of multiple thick,
electron-dense strands, each measuring ~80-180 nm in diameter (Huang et al., 1997
). Some of these strands are in
direct contact with the surface of the nucleolus. Furthermore, deletion mutagenesis studies showed that at least
three RNA recognition motifs at either the COOH or NH2
terminus of the PTB protein are required for it to be targeted to the PNC, suggesting that RNA binding is necessary for PTB to be localized in the PNC (Huang et al.,
1997
). However, the function of the PNC and its relationship to the transformed phenotype remains to be determined.
Thus far, several small RNAs transcribed by RNA polymerase III (RNase MRP RNA, RNase P RNA, and hY
RNAs) (Matera et al., 1995; Lee et al., 1996
) and two
hnRNP proteins, PTB (Ghetti et al., 1992
) and CUG-BP/
hNab50 (Timchenko et al., 1996
), have been identified in
the PNC. One of the hnRNP proteins in the PNC, PTB, is
a 57-kD RNA-binding protein that specifically binds pyrimidine-rich sequences (Ghetti et al., 1992
). PTB has been
shown to be involved in multiple cellular functions, including pre-mRNA splicing (Patton et al., 1993
; Singh et al.,
1995
; Ashiya and Grabowski, 1997
), splice site selection in
alternative pre-mRNA splicing (Lin and Patton, 1995
;
Perez et al., 1997
), RNA polyadenylation (Lou et al.,
1996
), and translational regulation of certain viral RNA
transcripts (Hellen et al., 1994
; Kaminski et al., 1995
;
Witherell et al., 1995
). PTB apparently participates in
these functions through the binding of pyrimidine-rich
RNA sequences. Therefore, PTB may serve as a bridge
between the pyrimidine tract containing RNAs and a variety of cellular factors to fulfill different cellular functions.
CUG-BP/hNab50, a second hnRNP protein localized to
the PNC, was initially isolated through a yeast two-hybrid
screen because of its interaction with the yeast hnRNP
protein Nab2p (Anderson et al., 1993). It was later revealed that CUG-BP/hNab50 binds to the CUG triplet
repeats of myotonin protein kinase RNA, which is associated with myotonic dystrophy, an autosomal dominant neuromuscular disease (Timchenko et al., 1996
). The
CUG-BP/hNab50 protein binds polyadenylated RNA and
is distributed predominantly in the nucleoplasm as well as
enriched in a locus at the periphery of the nucleolus (Timchenko et al., 1996
). Double labeling experiments showed
that the perinucleolar localization of the protein coincides
with the PNC (Huang, S., and D.L. Spector, unpublished
result). More recently, the phosphorylation and intracellular distribution of CUG-BP/hNab50 were shown to be altered in patients with myotonic dystrophy and in a myotonin protein kinase knockout mouse (Robert et al., 1997
). However, it was not reported whether the distribution of
this protein in the PNC is affected by the change in phosphorylation of the protein. The role of CUG-BP/hNab50
in the PNC is not yet clear.
In addition to the above-described hnRNP proteins, several RNA polymerase III transcripts (hY RNAs, RNase P
RNA, and RNase MRP RNA) have also been localized to
the PNC (Matera et al., 1995). hY RNAs, which range in
size from 69-112 nucleotides, interact with the 60-kD Ro
protein to form Ro RNPs. Ro RNPs are present predominantly in the cytoplasm at 1% the level of ribosomes
(Wolin and Steitz, 1984
), and their function is not known.
In spite of the presence of hY1, hY3, and hY5 RNAs, the
Ro protein itself was not found in the PNC (Matera et al.,
1995
). RNase P RNA is involved in tRNA and preribosomal RNA processing (for reviews see Altman, 1990
; Clayton, 1994
). RNase P RNA is localized in the cytoplasm and
diffusely in the nucleoplasm in addition to being present in
the PNC (Darr et al., 1992
; Matera et al., 1995
; Jacobson et
al., 1997
). When rhodamine-labeled RNase P RNA was injected into the nucleus of NRK cells, the labeled RNA
rapidly accumulated in the nucleolus followed by a redistribution into the nucleoplasm (Jacobson et al., 1997
). The
transient association with the nucleolus suggests that
RNase P RNA may be processed and assembled into
RNPs or play a role in the nucleolus (Jacobson et al.,
1997
). RNase MRP, another endoribonuclease, is involved in preribosomal RNA processing (for review see Clayton,
1994
). In situ hybridization and microinjection of labeled
RNase MRP RNA demonstrated that this RNA is localized in the nucleolus and the PNC (Clayton, 1994
; Jacobson et al., 1995
; Matera et al., 1995
). Not all RNAs transcribed by RNA polymerase III are detected in the PNC.
In situ hybridization with specific probes to hY4, 5S
rRNA, and U6 snRNA did not reveal hybridization signals in the PNC (Matera et al., 1993, 1995). The significance of the accumulation of several RNA polymerase III
transcripts in the PNC is presently unknown.
In this report, we demonstrate that the PNC is structurally distinct from the nucleolus and forms a reticulated mesh on a portion of the nucleolar surface. The PNC incorporates Br-UTP and FITC-CTP after a short pulse using permeabilized cells, suggesting that the PNC is involved in transcription. The structure of the PNC is altered upon the inhibition of RNA synthesis in cultured cells, suggesting that the integrity of the PNC reflects its transcriptional activity. Immunolabeling and in situ hybridization have shown that several pre-mRNA processing factors, including splicing factors (snRNPs and SC35) and a 3' end processing factor (poly(A) binding protein II [PAB II]), and poly(A) RNA are present in the PNC. In addition, fluorescence recovery after photobleaching (FRAP) analysis has shown that the hnRNP protein, PTB, turns over rapidly in the PNC. Together, these findings suggest that the PNC is a dynamic subnuclear structure that is involved in RNA metabolism in transformed cells.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell Culture
HeLa cells were grown to subconfluence on 22 × 22-mm glass coverslips
in 35-mm Petri dishes in Dulbecco's modified Eagle's minimum essential
medium (DMEM) supplemented with 10% fetal calf serum (FCS)
(GIBCO-BRL, Life Technologies, Inc., Rockville, MD). The inhibition of
RNA polymerase I transcription was achieved by the addition of actinomycin D (0.04 µg/ml for 3 h) (Perry, 1963). The inhibition of RNA polymerase II transcription was achieved by the addition of
-amanitin (50 µg/
ml for 5 h) (Kedinger et al., 1970
; Lindell et al., 1970
) or 5,6-dichloro-1-
-D-ribofuranosylbenzimidazole (DRB) (25 µg/ml for 3 h) (Sehgal et
al., 1976
) to the culture medium. Transcription inhibition was reversed
when DRB-containing medium was removed from cells and replaced with
fresh medium. Cycloheximide (Sigma Chemical Co., St. Louis, MO) was
added at 100 µg/ml for 5 h to inhibit protein synthesis and RNA polymerase I activity (Higashi et al., 1968
; Willems et al., 1969
; O'Keefe et al.,
1994
).
Three-dimensional Reconstruction of the PNC by Electron Microscopy
Transiently expressed GFP-PTB (Huang et al., 1997) was used as a
marker to indicate the localization of the PNC. The corresponding nuclear
region identified by fluorescence of the GFP-PTB fusion protein was examined by electron microscopy. Specifically, transfected cells were seeded
onto gridded glass coverslips. 12 h after transfection, cells were fixed in
4% paraformaldehyde with 0.05% glutaraldehyde in PBS, and cells that
showed the PNC were quickly photographed using an epifluorescence microscope (model FXA; Nikon, Inc., Melville, NY) equipped with a cooled
CCD camera (1320 × 1035, 6.7 µm pixel size) (SenSys; Photometrics, Inc.,
Tuscon, AZ) using Oncor Image software. Subsequently, cells were fixed
in 2% glutaraldehyde for 20 min and washed in PBS and 0.1 M cacodylate
buffer, pH 7.4. Cells were then postfixed in 1% osmium tetroxide containing 0.15% ferrous cyanide in 0.1 M cacodylate buffer, pH 7.4, for 1 h, dehydrated by incubation in a series of ascending concentrations of ethanol, and embedded in Epon/araldite at 60°C for 48 h. Serial 80-nm-thick sections were poststained with uranyl acetate-lead citrate, mounted on slot
grids, and examined at 80 keV with a transmission electron microscope
(model 100CX; JEOL U.S.A., Inc., Peabody, MA). The same cells photographed at the fluorescence microscopic level were located, and serial images of the nuclear regions that corresponded to the PNCs were recorded.
Outlines of the nucleoli and PNCs were hand traced on 11" × 14" photographic prints and digitized using a digitizing tablet and a software program described by Young et al. (1987)
. The section planes were aligned,
and volumes were surface-rendered using the programs SYNU and
SYNU-render as previously described by Hessler et al. (1992)
.
Nuclear Extraction
Cells were extracted following a modification of a protocol described by
Fey et al. (1986). Subconfluent cells grown on glass coverslips were rinsed
with PBS and incubated at 4°C for 10 min in CSK buffer (100 mM NaCl,
300 mM sucrose, 10 mM Pipes, pH 6.8, 3 mM MgCl2, 1 mM PMSF, and 2 mM vanadyl ribonucleoside complex) containing 0.5% Triton X-100 (vol/
vol). Cells were incubated at 4°C for 5 min in the CSK buffer containing
250 mM ammonium sulfate and 0.5% Triton X-100, treated with DNAse I
in CSK buffer with 50 mM NaCl for 30 min at 37°C or room temperature,
and finally fixed in 2% paraformaldehyde in PBS.
Transfection
Expression constructs were transiently transfected into HeLa cells by
electroporation (Spector et al., 1997). Subconfluent cells in a 100-mm culture dish were trypsinized and collected in DMEM supplemented with
10% FBS. Cells were then mixed with 20 µg of DNA including 7 µg target
DNA and 13 µg sheared salmon sperm DNA. 280 µl of cell-DNA mixture
was electroporated in a Bio-Rad electroporator (Hercules, CA) at 260 V
and 960 µF. Cells were subsequently seeded onto glass coverslips in 35-mm Petri dishes and were grown for either 7 or 24 h.
FRAP
Living cell studies were performed using a 35-mm Petri dish with a coverslip attached to the bottom. Transfected cells were grown on the coverslip for 24 h and observed using an inverted confocal laser-scanning microscope (model 410; Carl Zeiss, Inc., Thornwood, NY). An initial image was acquired, and a FRAP macro was used to photobleach a designated area of the nucleus. The photobleaching was accomplished using the 488-nm argon laser at 50% of its full power (25 mW) for 20 s. Immediately after the bleaching process, an averaged image was obtained. Multiple images were subsequently acquired within 5 min after bleaching, as indicated in Fig. 6.
|
Nucleotide Incorporation Assay
The transcription assay was modified from published studies (Jackson et
al., 1993; Wansink et al., 1993
). At 8 or 24 h after transfection, cells were
rinsed once with PBS and once with a Tris-glycerol buffer (20 mM Tris-HCl, pH 7.4, 5 mM MgCl2, 25% glycerol, 0.5 mM PMSF, and 0.5 mM
EGTA). Cells were then permeabilized in the same buffer containing 5 µg/ml digitonin at room temperature for 3 min. Subsequently, cells were
incubated in transcription cocktail (100 mM KCl, 50 mM Tris-HCl, pH
7.4, 5 mM MgCl2, 0.5 mM EGTA, 25% glycerol, 1 mM PMSF, 2 mM ATP,
0.5 mM CTP, 0.5 mM GTP, 0.2 mM Breakup or 0.4 mM FITC-CTP, and 1 U/ml RNasin) for 5 min at 37°C. At the end of the transcription reaction,
cells were gently rinsed three times with PBS and then fixed in 2% formaldehyde in PBS. Transcription inhibition was achieved by adding the corresponding drugs to the permeabilization buffer and transcription cocktail.
Immunolabeling
Subconfluent HeLa cells grown on glass coverslips were extracted with
CSK buffer containing 0.3% Triton X-100 for 3 min and fixed in freshly
made 2% formaldehyde in PBS for 15 min. Cells were washed three times
for 10 min each in PBS, and coverslips were incubated with primary antibody for 1 h at room temperature. Antibodies used in this study included
anti-PTB primary antibody, SH54 (Huang et al., 1997), at a dilution of
1:300, anti-Sm antibody (Lerner and Steitz, 1979
) at a dilution of 1:1,000,
anti-B
at a dilution of 1:10 (Habets et al., 1987
, 1989
), antifibrillarin (Sigma Chemical Co.) (Ochs et al., 1985
) at a dilution of 1:5, anti-SC35 at
a dilution of 1:1,000 (Fu and Maniatis, 1990
), anti-PAB II at a dilution of
1:10 (Krause et al., 1994
), or anticoilin at a dilution of 1:100 (Andrade et
al., 1993
). Cells were rinsed in PBS, incubated with Texas red-conjugated
goat anti-human, FITC- or Texas red-conjugated goat anti-mouse, or
Texas red goat anti-rabbit antibody at a dilution of 1:100 for 1 h at room
temperature, and then washed three times for 10 min each in PBS. The
coverslips were mounted onto glass slides with mounting medium containing 90% glycerol in PBS with 1 mg/ml paraphenylenediamine as an antifade agent. The mounting medium was adjusted to pH 8.0 with 0.2 M bicarbonate buffer (Spector et al., 1997
). Cells were examined with a
microscope (model FXA; Nikon, Inc.) equipped with epifluorescence and
differential interference contrast optics. Images were captured by a cooled CCD camera (1320 × 1035, 6.7 µm pixel size) (SenSys; Photometrics, Inc.)
using Oncor Image software.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The PNC Forms a Reticulated Mesh Associated with a Portion of the Nucleolar Surface
Previous examination of thin-sectioned and optimally
fixed HeLa cells revealed that the PNC is an electron-dense structure composed of thick strands, some of which
are in direct contact with the surface of the nucleolus
(Huang et al., 1997). We sought to determine if these thick
strands are interconnected and if they form a higher order
structure. To resolve the three-dimensional organization
of the PNC at high resolution, PNCs in serial thin sections
of optimally fixed HeLa cell nuclei were examined by electron microscopy (Materials and Methods). The sections
were poststained with uranyl acetate-lead citrate, and the
PNC was readily distinguishable from the nucleolus under
these conditions of specimen preparation. The PNC was
also identified by correlating the cell sections to a fluorescent image of the same cell in which the expression of
GFP-PTB (Huang et al., 1997
) marked the PNC (Fig. 1).
The PNC appeared to be more electron dense than the nucleolus and formed thick strands, some of which intimately
associate with the nucleolus. Images of serial sections were
aligned, and three-dimensional models were reconstructed
using the programs SYNU and SynuRender (Hessler et
al., 1992
) (Fig. 2). Such analysis has revealed that the PNC
is a highly interconnected and reticulated mesh associated
with a portion of the nucleolar surface. However, there is
considerable variability in the shape, size, and the relationship of the PNC with the nucleolus. In some cells, the PNC
is mostly positioned on the surface of the nucleolus (Fig. 2
A), while in others, the PNC extends into the nucleolus
like a plug (Fig. 2 B). Occasionally, a portion of the nucleolus extends into the PNC (Fig. 2 C). This variability may
represent the dynamic range of PNC:nucleolus interrelationships.
|
|
The PNC Is Actively Involved in Transcription
Based on the abundance of RNAs and RNA-binding proteins in the PNC, we were interested in examining if this
subnuclear compartment is involved in transcription. In
situ Br-UTP incorporation experiments were performed
to evaluate the transcriptional activity in the PNC. Cells
transiently expressing GFP-PTB, which marks the PNC, were briefly permeabilized and incubated in a transcription cocktail containing Br-UTP using a modified protocol
based on the work of Wansink et al. (1993) and Jackson et
al. (1993)
. Cells were then fixed, and the nuclear sites of
Br-UTP incorporation were detected by immunolabeling
with a monoclonal antibody that specifically recognizes
the Br epitope. Simultaneous detection of the incorporation sites (red signal) and the PNC, marked by GFP-PTB
(green signal), demonstrates that the PNC coincides with
sites of Br-UTP incorporation (Fig. 3, top row). In fact, the
Br-UTP incorporation is often more prominent in the
PNC than in most of the nucleoplasm. However, the size
and shape of the sites of Br-UTP incorporation often do
not completely overlap with the PNC. The incorporation
was inhibited when it was performed at 4°C and was not
detected in the presence of RNase A (data not shown),
suggesting that the nucleotides are incorporated into the
RNA in an energy-dependent reaction. The nucleotide incorporation could result from either transcription or posttranscriptional modification of nascent RNA, including
editing and uridinylation. It has previously been shown that U is posttranscriptionally added to certain small RNA
polymerase III transcripts, including RNase MRP RNA
(Hashimoto and Steitz, 1983
; Yuan et al., 1989
), which is
found in the PNC. To determine the nature of the Br-UTP
incorporation in the PNC, we examined whether the incorporation is DNA dependent and whether the PNC incorporates nucleotides other than Br-UTP. We found that the Br-UTP incorporation in the PNC and the entire nucleus
(Fig. 3, second row) was inhibited in the presence of a high
concentration of actinomycin D (50 µg/ml) (Perry, 1963
),
which intercalates into DNA and prevents it from being
used as a transcription template. Furthermore, addition of
FITC-CTP to the transcription cocktail resulted in an incorporation in the PNC that is similar to the incorporation
of Br-UTP (Fig. 3, third row). These findings further demonstrate that the nucleotide incorporation into the PNC is the consequence of transcription.
|
To identify which RNA polymerase is involved in the
Br-UTP incorporation in the PNC, transcription inhibitors
that preferentially inhibit different RNA polymerases
were added individually to the transcription cocktail. To
inhibit RNA polymerase I activity, two alternative approaches were used. Actinomycin D, which inhibits RNA
polymerase I at low concentration (Perry, 1963), was
added, and the concentration used was titrated such that
the nucleolar incorporation of Br-UTP was significantly
reduced and the nucleoplasmic incorporation did not exhibit a detectable change (Fig. 3, fourth row). At this concentration of actinomycin D, no significant change was observed in the Br-UTP incorporation in the PNC (Fig. 3,
fourth row). Alternatively, cells were pretreated with cycloheximide (100 µg/ml) for up to 5 h before the Br-UTP
incorporation assay. Cycloheximide has been shown to inhibit protein synthesis as well as RNA polymerase I transcription by limiting essential labile factors (Higashi et al.,
1968
; Willems et al., 1969
; O'Keefe et al., 1994
). The indirect inhibition of RNA polymerase I by inhibiting protein
synthesis enables cycloheximide to circumvent the potential accessibility problem that other drugs might have. The
treatment of cycloheximide inhibited most of Br-UTP incorporation in the nucleolus but did not appreciably alter
the incorporation in the PNC (Fig. 3, fifth row). The similar results obtained by using two different inhibitory
mechanisms suggests that RNA polymerase I is unlikely to
be responsible for the Br-UTP incorporation in the PNC.
To examine whether RNA polymerases II and/or III are involved, we added
-amanitin into the transcription cocktail.
-Amanitin specifically and selectively inhibits RNA
polymerase II at a low concentration of 50 µg/ml (Stripe
and Fiume, 1967
; Weinmann et al., 1975
) and inhibits both
polymerases II and III at a high concentration of 300 µg/
ml (Weinmann and Roeder, 1974
). Surprisingly, the addition of
-amanitin at either the low or high concentration
did not significantly change the Br-UTP incorporation in
the PNC (Fig. 3, bottom row), despite a significant reduction in nucleoplasmic incorporation. Since the Br-UTP incorporation in the PNC is due to the transcription that occurs within the 5 min of pulse labeling as described above,
and since we have ruled out the involvement of RNA
polymerase I transcription, it is therefore most likely that
RNA polymerase II and/or III are responsible for the synthesis of nascent RNA in the PNC. A reasonable explanation for a lack of transcription inhibition may be the inability of
-amanitin to gain access into the PNC.
The Structural Integrity of the PNC Is Sensitive to Transcriptional Inhibition
To examine if inhibition of transcription would influence
the structure of the PNC in vivo, HeLa cells were treated
with -amanitin at 50 µg/ml for 5 h. The structure of the
PNC showed a marked alteration after inhibition of RNA
polymerase II (Fig. 4, A and C). The PNC is no longer a
compact structure with clear boundaries after
-amanitin
treatment. PTB (green) seems to extend from what appears to be the original site of the PNC into the nucleoplasm and, in many cases, forms a series of dots in a rosette with a hollow center (Fig. 4 A, arrow and arrowhead;
area at the arrow is enlarged in the inset). When double labeled with the anti-Sm antibody (red), a colocalization was
observed between the original sites of the PNC and snRNPs. Interestingly, the extended rosette-shaped dots surround the round snRNP clusters (Fig. 4 C, arrow and arrowhead; area at the arrow is enlarged in the inset). Such
alterations appear to form a gradient that decreases with
distance from the original locus (the strongly stained region) of the PNC. In contrast, inhibition of RNA polymerase II transcription exerts little to no effect on the diffuse nuclear distribution pattern of PTB in cells that do
not have a PNC (Fig. 4 D), demonstrating that the observed alteration is specific to the PNC. Similar changes
were also observed when cells were treated with DRB, another RNA polymerase II inhibitor that inhibits a major
nuclear Ser/Thr protein kinase, casein kinase II (Sehgal et al.,
1976
; Zandomeni and Weinmann, 1984
). These changes
were reversible after cells were grown in drug-free medium for 2 h (data not shown), indicating that the observed
alteration in the structure of the PNC is unlikely to be the
result of cell death. These findings show that the integrity of the PNC is dependent upon the transcriptional activity
of RNA polymerase II.
|
Examination of another hnRNP protein, CUG-BP/
hNab50, during transcription inhibition using monoclonal
antibody 3B1 (Timchenko et al., 1996), which specifically
recognizes CUG-BP/hNab50, revealed a similar reorganization of the PNC. However, in contrast to PTB, most of
the soluble nucleoplasmic CUG-BP/hNab50 is localized to the cytoplasm when RNA polymerase II transcription is
inhibited by
-amanitin. This finding suggests that CUG-BP/hNab50 may belong to the group of hnRNPs that shuttle between the nucleus and cytoplasm in a transcription-dependent manner (for review see Siomi and Dreyfuss,
1997
). However, the fraction of CUG-BP/hNab50 that is present in the PNC remains in the nucleus and is colocalized with PTB in the structurally altered PNC (Fig. 4, G-I).
In cells that do not contain a PNC, CUG-BP/hNab50 is not
detected in the nucleus upon transcription inhibition (data
not shown).
When cells in culture were treated for 2-5 h with actinomycin D at a concentration that either selectively inhibits
RNA polymerase I (0.04 µg/ml) or all RNA polymerases
(10 µg/ml) (Perry, 1963), the PNC was no longer detected
by immunolabeling using monoclonal antibodies SH54 or
3B1 (data not shown). However, when cells were treated
with cycloheximide (a protein synthesis inhibitor) at 100 µg/ml for up to 5 h, little change was observed in the structure of the PNC (data not shown). Since cycloheximide
also inhibits RNA polymerase I activity by inhibiting the
synthesis of necessary labile factors (Higashi et al., 1968
;
Willems et al., 1969
; O'Keefe et al., 1994
), the resistance to
cycloheximide treatment suggests that the structural integrity of the PNC is not dependent on RNA polymerase I
transcription or protein synthesis. This finding is consistent with the observation in permeabilized cells that the
Br-UTP incorporation in the PNC does not reflect RNA
polymerase I transcription. As previous studies showed
that treatment with actinomycin D causes nucleolar fragmentation (Reynolds et al., 1964
; Ochs et al., 1985
), it is
not clear whether the disappearance of the PNC after actinomycin D treatment is due to other effects of the drug
rather than the inhibition of RNA polymerase I activity.
The PNC Contains Poly(A) RNA and Pre-mRNA Processing Factors
Incorporation of Br-UTP together with the presence of
RNA transcripts and hnRNP proteins in the PNC suggest
that the PNC is involved in RNA metabolism. To further
investigate the function of the PNC, we examined it for the
presence of polyadenylated RNA, pre-mRNA splicing factors, and a 3' end processing factor. In situ hybridization in
HeLa cells using a biotinylated oligo (dT)50 probe (Huang
et al., 1994) revealed that poly(A) RNA is present in the
PNC in addition to being distributed throughout the nucleus in a diffuse and speckled pattern (Fig. 5, top row). The labeling of the poly(A) RNA in some PNCs is at a
similar intensity as the larger nuclear speckles. In other
PNCs, the labeling intensity of poly(A) RNA is indistinguishable from the diffuse nuclear labeling (data not
shown).
|
Immunolabeling of pre-mRNA splicing factors including U2 snRNPs (Habets et al., 1987, 1989
), SC35 (Fu and
Maniatis, 1990
), and a 3' end processing factor, PAB II
(Krause et al., 1994
), showed that these factors are present
in the PNC in addition to their previously characterized
sites of localization (Fig. 5). However, the labeling intensity varies among PNCs. To exclude the possibility that the
labeling in the PNC is simply due to the diffuse nuclear
staining of these factors, we examined the localization of
another diffusely distributed nuclear component, p80 coilin. Coilin, an 80-kD protein, is diffusely distributed in the
nucleus in addition to being present in coiled bodies (for reviews see Brasch and Ochs, 1992
; Lamond and Carmo-Fonseca, 1993
; Gall et al., 1995
; Roth, 1995
). When coilin
was localized with anticoilin antibody (Andrade et al.,
1993
), no staining of PNCs was observed (Fig. 5, bottom
row). The presence of RNA processing factors and
poly(A) RNA in the PNC is consistent with the idea that
the PNC is a site of transcription and that RNA polymerase II is one of the transcription systems involved.
Furthermore, these findings suggest that posttranscriptional processing of certain transcripts may also occur in
the PNC.
PTB Turns Over Rapidly in the PNC
To understand the dynamics of the hnRNP proteins in the PNC, we used FRAP to examine the turnover of GFP- PTB in the PNC (see Materials and Methods). Cells transfected with the GFP-PTB construct were examined using a confocal laser-scanning microscope (Carl Zeiss, Inc., Thornwood, NY). Cells with two PNCs were chosen so that one of them served as a marker to monitor the specificity of bleaching and the stability of the focal plane. An initial image was captured before photobleaching. The PNC was photobleached for 20 s by exposure to the 488-nm laser line using the line scanning mode. An averaged image was obtained immediately after photobleaching followed by a series of images at different time points (Fig. 6, top and middle rows). The photobleaching resulted in a nearly complete loss of the GFP-PTB labeling in the targeted PNC. The bleaching was specific since the neighboring PNC, which was separated by a few micrometers, was not affected. 25 s after the bleaching, the GFP-PTB began to reappear in the PNC, and the fluorescent intensity in the PNC recovered to a similar level as before the bleaching process within 5 min. The rapid recovery suggests that the unbleached GFP-PTB in the nucleoplasm quickly enters the PNC. Moreover, the quantitatively large degree of recovery indicates that GFP-PTB is highly mobile in the PNC and that there is not a large immobile fraction of the protein. To exclude the possibility that the recovery of the GFP-PTB labeling in the PNC is due to a spontaneous fluorescence recovery of GFP-PTB, fixed cells expressing GFP-PTB were examined by FRAP in an identical manner (Fig. 6, bottom row). Again, a complete photobleaching of the labeled PNC was achieved without affecting an adjacent PNC. However, recovery of the fluorescence in the bleached PNC was not observed up to 30 min. The result of the control experiment confirmed that the fluorescence recovery observed in living cells is most likely due to the rapid turnover of PTB in the PNC. The rapid turnover of this hnRNP protein in the PNC is consistent with the dynamic nature of a transcription site with regard to RNA synthesis and subsequent transport of processed product away from the transcription site.
The PNC Is Associated with an Insoluble Fraction of the Nucleus
To determine the solubility of the PNC, HeLa cells were
first extracted with 0.5% Triton X-100, followed by treatment with 250 mM ammonium sulfate and subsequent
DNase I digestion (Fey et al., 1986). Cells were then fixed
and immunostained with SH54, a previously characterized
monoclonal antibody that specifically recognizes PTB in
the PNC (Huang et al., 1997
), and human antifibrillarin antibody (Sigma Chemical Co.) (Ochs et al., 1985
), which
marks the nucleolus. PTB in the PNC remains detectable
at the periphery of the nucleolus after the extraction procedure (Fig. 7 A, arrowhead). The PNCs in these preparations appear to be more rounded and smaller in size than
in unextracted cells. In contrast to the pool of PTB in the
PNC, the diffusely localized nucleoplasmic pool of PTB
decreased significantly upon extraction, concomitant with an increase in the staining of the protein in the nucleolus
(Fig. 7 A), which was identified by immunolabeling with
the antifibrillarin antibody (Fig. 7 B). To examine whether
PTB in the nucleolus is derived from the PNC, Detroit 551 cells (normal human fibroblasts), only 2% of which display
visible PNCs, were prepared using the same protocol. A
similar relocation of nucleoplasmic PTB to the nucleolus
was observed in all of the cells in spite of the absence of
the PNC in these cells (Fig. 7 D). The simplest explanation is that the extraction leads to the release of PTB from
binding to components that are responsible for its diffuse
nuclear distribution pattern, and it is then relocated into
the nucleoli. These observations demonstrate that the
PNC-associated PTB represents a less soluble fraction
than the diffuse nuclear population of this protein.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the present study, we have shown that the PNC actively
incorporates Br-UTP and FITC-CTP in a transcription assay using permeabilized cells. Many studies have used this
assay to investigate transcription patterns in the cell nucleus (Hozak et al., 1994; Aoki et al., 1997
; Fay et al., 1997
;
Neugebauer and Roth, 1997
) since its initial establishment
(Jackson et al., 1993
; Wansink et al., 1993
). Our observation that the PNC actively incorporates labeled nucleotides in a DNA-dependent manner after 5 min of pulse labeling suggests that the PNC is a site of transcription. Inhibition of RNA polymerase I either by addition of actinomycin D in the transcription cocktail or by pretreatment of
cells with cycloheximide does not affect the Br-UTP incorporation, indicating that transcription of nascent RNA in
the PNC is unlikely to involve RNA polymerase I. This
finding is consistent with the report by Matera et al. (1995)
that 28S rRNA was not detected in the PNC using in situ hybridization and our previous findings that fibrillarin,
which is required for rRNA processing, is not present in
the PNC (Huang et al., 1997
). RNA polymerases II and/or
III may be responsible for the transcription occurring in
the PNC, although it is not clear at the present time
whether both polymerases are involved. Consistent with
this suggestion are the findings that poly(A) RNA and
small RNAs transcribed by RNA polymerase III, including hY RNAs, RNase MRP RNA, and RNase P RNA
(Matera et al., 1995
), are detected in the PNC. Furthermore, immunocytochemical labeling revealed that RNA
processing factors, including snRNPs, SC35, and PAB II,
are present in the PNC. SnRNPs and SC35 primarily participate in the processing of RNA polymerase II transcripts, and PAB II binds to polyadenylated RNA transcribed by both RNA polymerase II and III. It has become
increasingly evident from morphological and biochemical
studies that RNA transcription and processing are spatially and temporally linked (Beyer et al., 1980
; Beyer and
Osheim, 1988
; Jiménez-García and Spector, 1993
; Xing
and Lawrence, 1993
; Zhang et al., 1994
; Bauren et al.,
1996
; Huang and Spector, 1996
; Du and Warren, 1997
;
Kim et al., 1997
; McCracken et al., 1997
; Misteli et al.,
1997
; Zeng et al., 1997
). The presence of RNA processing
factors in the PNC supports the notion that the PNC is a
site of transcription and suggests that it may also be involved in RNA processing. However, we cannot exclude
the possibility that the rapid accumulation of newly synthesized RNA transcripts in the PNC may be the result of
transcription elsewhere in the nucleus and the subsequent
very rapid translocation of these transcripts to the PNC.
As described in a previous study by Matera et al. (1995)
,
the chromosome segment that encodes two of the hY
RNAs only showed an occasional association with the PNC. In addition, the La protein known to be at least transiently associated with newly synthesized RNA polymerase III transcripts was not detected in the PNC using
immunocytochemical labeling (Matera et al., 1995
). Very
recently, two other nuclear bodies were found to incorporate tagged nucleotides after a short pulse labeling (LaMorte et al., 1998
; Pombo et al., 1998
). Promyelocytic leukemia (PML) bodies and coiled bodies rapidly accumulate
FITC-UTP upon microinjection into cells, and PML bodies were also shown to contain a transcription factor,
cAMP-regulated enhancer binding protein (CREB) binding protein (LaMorte et al., 1998
). In addition, the polymorphic interphase karyosomal association (PIKA) domain was shown to be associated with specific chromosomes
and to also be active in transcription (Pombo et al., 1998
).
These observations, together with our finding that the
PNC accumulates nascent RNA, suggest that transcription
may be spatially regulated in subnuclear compartments.
Further studies will identify transcripts that are synthesized and/or processed in the PNC.
Based upon the extraction behavior and structural alterations during transcription inhibition, two populations of the hnRNP proteins PTB and CUG-BP/hNab50 were identified in the HeLa cell nucleus. One population is diffusely distributed throughout the nucleoplasm, and the other population is enriched in the PNC with a much higher fluorescent intensity, implying a higher protein concentration. The PNC-associated hnRNP proteins are linked with the less soluble fraction of the nucleus and remain associated with the structurally altered PNC during transcription inhibition, whereas the diffusely distributed nuclear populations are removed by the extraction, and CUG-BP/hNab50 is relocated to the cytoplasm during transcription inhibition. These differences suggest that the two populations of hnRNP proteins, the PNC-associated and the diffuse nucleoplasmic, each may interact with a different set of cellular constituents. Since the PNC is predominantly observed in cells with a transformed phenotype, we speculate that the PNC-associated hnRNP proteins may be complexed with cellular components that are altered in terms of their expression or modification in transformed cells. Future studies will focus on the isolation and identification of these constituents.
An increasing number of nuclear bodies or inclusions
have been described in recent years from cells or tissues
that have altered physiology or are derived from various
disease-related samples. For example, coiled bodies, round
and electron-dense structures, are often observed in transformed and cancer cell lines (Spector et al., 1992; Ochs et
al., 1994
). Coiled bodies contain snRNPs, U3 snoRNP,
fibrillarin, NOPP140, and p80-coilin (for reviews see Lamond and Carmo-Fonseca, 1993
; Gall et al., 1995
; Roth,
1995
). Several snRNA genes (U1, U2, and U3) are localized adjacent to coiled bodies in a percentage of cases
(Frey and Matera, 1995
; Smith et al., 1995
; Gao et al.,
1997
). Recently, LaMorte et al. (1998)
have localized nascent RNA in coiled bodies, and a transcription factor,
TFIIH, was also detected in coiled bodies (Jordan and Carmo-Fonseca, 1997
). However, the exact function of
coiled bodies remains unknown. A second nuclear structure, "gems" (gemini of coiled body), was shown to be frequently associated with coiled bodies (Liu and Dreyfuss,
1996
). Gems contain the survival of motor neurons (SMN)
protein that is encoded by a gene responsible for spinal
muscular atrophy (Liu et al., 1997
). The SMN protein was
shown to interact with snRNPs that are involved in pre-mRNA splicing and with a cellular protein called SIP1
through a separate interaction (Liu et al., 1997
). The
SMN-SIP1 complex was shown to be involved in snRNP
biogenesis (Fischer et al., 1997
; Liu et al., 1997
). PML bodies, also named ND10 (nuclear domain 10) and POD
(PML oncogenic domains), change their number and size in acute promyleocytic leukemia (Ascoli and Maul, 1991
;
Dyck et al., 1994
; Koken et al., 1994
, 1995
; Weis et al.,
1994
; Terris et al., 1995
; for review see Doucas and Evans,
1996
). Generally, each cell nucleus contains ~10-20 PML
bodies ranging from 0.3 to 1 µm in diameter. In acute
promyleocytic leukemia cells, PML bodies break up into a
large number of microparticulates (Dyck et al., 1994
). Recently, LaMorte et al. (1998)
have localized nascent RNA
polymerase II transcripts and CREB binding protein to a
subset of PML bodies, suggesting that at least some PML
bodies are involved in transcription. Nuclear inclusions,
containing Huntington protein, are found in neurons involved in Huntington's Disease (Davies et al., 1997
). Patients with Huntington's Disease have an expanded NH2-terminal polyglutamine region in Huntington, and its
length influences the extent of Huntington accumulation within the intranuclear inclusions (DiFiglia et al., 1997
).
The presence of ubiquitin in these structures suggests that
the abnormal Huntington is targeted for proteolysis (DiFiglia et al., 1997
). Another recent example of a disease-related nuclear inclusion is the change in the subnuclear
localization of the ataxin-1 protein, which is associated
with the neurodegenerative disorder, Spinocerebellar ataxia
type I. The disease-related mutant ataxin-1, with an expanded polyglutamine tract, localizes to a single ~2-µm
structure compared with the normal ataxin-1 protein,
which localizes to several 0.5-µm nuclear structures (Skinner et al., 1997
). Ataxin-1 interacts with a cerebellar leucine-rich acidic nuclear protein in a manner such that the
affinity of the association depends upon the number of
glutamines in mutant ataxin-1 (Matilla et al., 1997
). All of these examples demonstrate that nuclear structure is altered in response to changes in cellular physiology and/or
pathology of cells or tissues. These changes may reflect
changes of nuclear function and/or regulation. Although
many nuclear bodies and inclusions have been described
morphologically, the functional relationship between many
of these structural changes and the respective diseases that
they are associated with are not clear. Our finding that the
PNC is potentially involved in transcription gives us an important clue to further address the molecular basis of the
PNC and its relationship with the transformed phenotype.
![]() |
Footnotes |
---|
Received for publication 2 June 1998 and in revised form 13 August 1998.
This study is supported by a grant from the National Institute of General Medical Sciences (GM42694) to D.L. Spector and a grant from the
National Cancer Institute (K01 CA74988-02) to S. Huang.
Address all correspondence to Sui Huang, Department of Cell and Molecular Biology, Northwestern University Medical School, 303 E. Chicago
Ave., Chicago, IL 60611. Tel.: (312) 503-4269. Fax: (312) 503-7912. E-mail:
s-huang2{at}nwu.edu
We would like to thank Tamara Howard for her enthusiastic technical assistance. We are very grateful to Dr. Maurice S. Swanson for the 3B1 antibody.
![]() |
Abbreviations used in this paper |
---|
DRB, 5,6-dichloro-1--D-ribofuranosylbenzimidazole;
FRAP, fluorescence recovery after photobleaching;
GFP, green fluorescent protein;
hnRNP, heterogeneous ribonucleoprotein;
PAB II, poly(A) binding protein II;
PML, promyleocytic leukemia;
PNC, perinucleolar compartment;
PTB, polypyrimidine binding protein;
SMN, survival of motor neurons.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. |
Altman, S..
1990.
Ribonuclease P.
J. Biol. Chem
265:
20053-20056
|
2. | Anderson, J.T., S.M. Wilson, K.V. Datar, and M.S. Swanson. 1993. NAB2: a yeast nuclear polyadenylated RNA-binding protein essential for cell viability. Mol. Cell. Biol. 13: 2730-2741 [Abstract]. |
3. | Andrade, L.E.C., E.M. Tan, and E.K.L. Chan. 1993. Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc. Natl. Acad. Sci. USA 90: 1947-1951 [Abstract]. |
4. | Aoki, F., D.M. Worrad, and R.M. Schultz. 1997. Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev. Biol. 181: 296-307 |
5. | Ascoli, A.C., and G.G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112: 785-795 [Abstract]. |
6. | Ashiya, M., and P.J. Grabowski. 1997. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA. 3: 996-1015 [Abstract]. |
7. | Bauren, G., W.Q. Jiang, K. Bernholm, F. Gu, and L. Wieslander. 1996. Demonstration of a dynamic, transcription-dependent organization of pre-mRNA splicing factors in polytene nuclei. J. Cell Biol. 133: 929-941 [Abstract]. |
8. | Beyer, A.L., and Y.N. Osheim. 1988. Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. Genes Dev. 2: 754-765 [Abstract]. |
9. | Beyer, A.L., O.L. Miller, and S.L. McKnight. 1980. Ribonucleoprotein structure in nascent hnRNA is nonrandom and sequence-dependent. Cell. 20: 75-84 |
10. | Brasch, K., and R.L. Ochs. 1992. Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp. Cell Res. 202: 211-223 |
11. |
Clayton, D.A..
1994.
A nuclear function for RNase MRP.
Proc. Natl. Acad. Sci.
USA
91:
4615-4617
|
12. | Darr, S.C., J.W. Brown, and N.R. Pace. 1992. The varieties of RNase P. Trends Biol. Sci. 17: 178-182 . |
13. | Davies, S.W., M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, and C.A. Ross. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90: 537-548 |
14. |
DiFiglia, M.,
E. Sapp,
K.O. Chase,
S.W. Davies, and
G.P. Bates.
1997.
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
Science.
277:
1990-1993
|
15. | Doucas, V., and R.M. Evans. 1996. The PML nuclear compartment and cancer. Biochim. Biophys. Acta 1288: M25-M29 |
16. |
Du, L., and
S.L. Warren.
1997.
A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing.
J. Cell
Biol.
136:
5-18
|
17. | Dyck, J.A., G.G. Maul, W.H. Miller Jr., J.D. Chen, A. Kakizuka, and R.M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 76: 333-343 |
18. | Fay, F.S., K.L. Taneja, S. Shenoy, L. Lifshitz, and R.H. Singer. 1997. Quantitative digital analysis of diffuse and concentrated nuclear distributions of nascent transcripts, SC35 and poly(A). Exp. Cell Res. 231: 27-37 |
19. | Fey, E.G., G. Krochmalnic, and S. Penman. 1986. The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J. Cell Biol. 102: 1654-1665 [Abstract]. |
20. | Fischer, U., Q. Liu, and G. Dreyfuss. 1997. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell. 90: 1023-1029 |
21. |
Frey, M.R., and
A.G. Matera.
1995.
Coiled bodies contain U7 small nuclear
RNA and associate with specific DNA sequences in interphase human cells.
Proc. Natl. Acad. Sci. USA.
92:
5915-5919
|
22. | Fu, X.-D., and T. Maniatis. 1990. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature. 343: 437-441 |
23. | Gall, J.G., A. Tsvetkov, Z. Wu, and C. Murphy. 1995. Is the sphere organelle/ coiled body a universal nuclear component? Dev. Genet. 16: 25-35 |
24. |
Gao, L.,
M.R. Frey, and
A.G. Matera.
1997.
Human genes encoding U3 snRNA
associate with coiled bodies in interphase cells and are clustered on chromosome 17p11.2 in a complex inverted repeat structure.
Nucleic Acids Res.
25:
4740-4747
|
25. | Ghetti, A., S. Piñol-Roma, W.M. Michael, C. Morandi, and G. Dreyfuss. 1992. hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 20: 3671-3678 [Abstract]. |
26. |
Habets, W.J.,
M.H. Hoet,
B.A.W. De Jong,
A. Van der Kemp, and
W.J. van
Venrooij.
1989.
Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally induced mouse monoclonal antibodies.
J. Immunol.
143:
2560-2566
|
27. |
Habets, W.J.,
P.T.G. Sillekens,
M.H. Hoet,
J.A. Schalken,
A.J.M. Roebroek,
J.A.M. Leunissen, and
W.J.M. van de Ven.
1987.
Analysis of a cDNA clone
expressing a human autoimmune antigen: full-length sequence of the U2
small nuclear RNA-associated B![]() |
28. |
Hashimoto, C., and
J.A. Steitz.
1983.
Sequential association of nucleolar 7-2 RNA with two different autoantigens.
J. Biol. Chem.
258:
1379-1382
|
29. | Hellen, C.U., T.V. Pestova, M. Litterst, and E. Wimmer. 1994. The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5' nontranslated region. J. Virol. 68: 941-950 [Abstract]. |
30. | Hessler, D., S.J. Young, B.O. Carragher, M.E. Martone, S. Lamont, M. Whittaker, R.A. Milligan, E. Masliah, J.E. Hinshaw, and M.H. Ellisman. 1992. Programs for visualization in three-dimensional microscopy. Neuroimage. 1: 55-67 . |
31. | Higashi, K., T. Matsuhisa, A. Kitao, and Y. Sakamoto. 1968. Selective suppression of nucleolar RNA metabolism in the absence of protein synthesis. Biochim. Biophys. Acta. 166: 388-393 |
32. | Hozak, P., P.R. Cook, C. Schofer, W. Mosgoller, and F. Wachtler. 1994. Site of transcription of ribosomal RNA and intranucleolar structure in HeLa cells. J. Cell Sci. 19: 109-113 . |
33. | Huang, S., and D.L. Spector. 1996. Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription. J. Cell Biol. 133: 719-732 [Abstract]. |
34. | Huang, S., T. Deerinck, M.H. Ellisman, and D.L. Spector. 1994. In vivo analysis of the stability and transport of nuclear poly(A)+ RNA. J. Cell Biol. 126: 877-899 [Abstract]. |
35. |
Huang, S.,
T. Deerinck,
M.H. Ellisman, and
D.L. Spector.
1997.
The dynamic
organization of the perinucleolar compartment in the mammalian cell nucleus.
J. Cell Biol.
137:
965-974
|
36. | Jackson, D.A., A.B. Hassan, R.J. Errington, and P.R. Cook. 1993. Visualization of focal sites of transcription within human nuclei. EMBO (Eur. Mol. Biol. Organ.) J. 12: 1059-1065 [Abstract]. |
37. | Jacobson, M.R., L.G. Gao, Y.L. Wang, and T. Pederson. 1995. Dynamic localization of RNase MRP RNA in the nucleolus observed by fluorescent RNA cytochemistry in living cells. J. Cell Biol. 131: 1649-1659 [Abstract]. |
38. |
Jacobson, M.R.,
L.G. Gao,
K. Taneja,
R.H. Singer,
Y.L. Wang, and
T. Pederson.
1997.
Nuclear domains of the RNA subunit of RNase P.
J. Cell Sci.
110:
829-837
|
39. | Jiménez-García, L.F., and D.L. Spector. 1993. In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell. 73: 47-59 |
40. | Jordan, P.C., and M. Carmo-Fonseca. 1997. The cdk7-cyclin H-MAT1 complex associated with TFIIH is localized in coiled bodies. Mol. Biol. Cell. 8: 1207-1217 [Abstract]. |
41. | Kaminski, A., S.L. Hunt, J.G. Patton, and R.J. Jackson. 1995. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA. 1: 924-938 [Abstract]. |
42. |
Kedinger, C.,
J.L. Gniazdowski,
J.L. Mandel Jr.,
F. Gissinger, and
P. Chambon.
1970.
![]() |
43. |
Kim, E.,
L. Du,
D.B. Bregman, and
S.L. Warren.
1997.
Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA.
J. Cell Biol.
136:
19-28
|
44. | Koken, M.H., F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Caivo, and C. Chomienne. 1994. The t(15:17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO (Eur. Mol. Biol. Organ.) J. 13: 1073-1083 [Abstract]. |
45. | Koken, M.H., C.G. Linares, F. Quignon, A. Viron, A.M. Chelbi, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de-The. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 10: 1315-1324 |
46. | Krause, S., S. Fakan, K. Weis, and E. Wahle. 1994. Immunodetection of poly(A) binding protein II in the cell nucleus. Exp. Cell Res. 214: 75-82 |
47. | Lamond, A.I., and M. Carmo-Fonseca. 1993. The coiled body. Trends Cell Biol. 3: 198-204 . |
48. |
LaMorte, V.J.,
J.A. Dyck,
R.L. Ochs, and
R.M. Evans.
1998.
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear
body.
Proc. Natl. Acad. Sci. USA.
95:
4991-4996
|
49. |
Lee, B.,
A.G. Matera,
D.C. Ward, and
J. Craft.
1996.
Association of RNase mitochondrial RNA processing enzyme with ribonuclease P in higher ordered
structures in the nucleolus: a possible coordinate role in ribosome biogenesis.
Proc. Natl. Acad. Sci. USA.
93:
11471-11476
|
50. | Lerner, M.R., and J.A. Steitz. 1979. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 76: 5495-5499 [Abstract]. |
51. | Lin, C.H., and J.G. Patton. 1995. Regulation of alternative 3' splice site selection by constitutive splicing factors. RNA. 1: 234-245 [Abstract]. |
52. |
Lindell, T.J.,
F. Weinberg,
P.W. Morries,
R.G. Roeder, and
W.J. Rutter.
1970.
Specific inhibition of nuclear RNA polymerase II by ![]() |
53. | Liu, Q., and G. Dreyfuss. 1996. A novel nuclear structure containing the survival of motor neurons protein. EMBO (Eur. Mol. Biol. Organ.) J. 15: 3555-3565 [Abstract]. |
54. | Liu, Q., U. Fischer, F. Wang, and G. Dreyfuss. 1997. The spinal muscular atrophy disease gene product SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 90: 1013-1021 |
55. | Lou, H., R.F. Gagel, and S.M. Berget. 1996. An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev. 10: 208-219 [Abstract]. |
56. | Matera, A.G., and D.C. Ward. 1993. Nucleoplasmic organization of small nuclear ribonucleoproteins in cultured human cells. J. Cell Biol. 121: 715-727 [Abstract]. |
57. | Matera, A.G., M.R. Frey, K. Margelot, and S.L. Wolin. 1995. A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I. J. Cell Biol. 129: 1181-1193 [Abstract]. |
58. | Matilla, A., B.T. Koshy, C.J. Cummings, T. Isobe, and H.T. Orr. 1997. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature. 389: 974-978 |
59. | McCracken, S., N. Fong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S.D. Patterson, M. Wickens, and D.L. Bentley. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature. 385: 357-361 |
60. | Misteli, T., J.F. Cáceres, and D.L. Spector. 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature. 387: 523-527 |
61. | Neugebauer, K.M., and M.B. Roth. 1997. Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription. Genes Dev. 11: 1148-1159 [Abstract]. |
62. | Ochs, R.L., M.A. Lischwe, W.H. Spohn, and H. Busch. 1985. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol. Cell. 54: 123-134 |
63. |
Ochs, R.L.,
T.W.J. Stein, and
E.M. Tan.
1994.
Coiled bodies in the nucleolus of
breast cancer cells.
J. Cell Sci.
107:
385-399
|
64. | O'Keefe, R.T., A. Mayeda, C.L. Sadowski, A.R. Krainer, and D.L. Spector. 1994. Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors. J. Cell Biol. 124: 249-260 [Abstract]. |
65. | Patton, J.G., E.B. Porro, J. Galceran, P. Tempst, and B. Nadal-Ginard. 1993. Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev. 7: 393-406 [Abstract]. |
66. | Perez, I., C.H. Lin, J.G. McAfee, and J.G. Patton. 1997. Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo. RNA. 3: 764-778 [Abstract]. |
67. | Perry, R.P.. 1963. Selective effects of actinomycin D on the intracellular distribution of RNA synthesis in tissue culture cells. Exp. Cell Res. 29: 400-406 . |
68. | Pombo, A., P. Cuello, W. Schul, J.-B. Yoon, R.G. Roeder, P.R. Cook, and S. Murphy. 1998. Regional and temporal specialization in the nucleus: a transcriptionally-active nuclear domain rich in PTF, Oct1 and PIKA antigens associates with specific chromosomes early in the cell cycle. EMBO (Eur. Mol. Biol. Organ.) J. 6: 1768-1778 . |
69. | Reynolds, R.C., P.O.B. Montgomery, and B. Hughes. 1964. Nucleolar "caps" produced by actinomycin D. Cancer Res. 24: 1269-1277 |
70. |
Robert, R.,
N.A. Timchenko,
J.W. Miller,
S. Reddy,
C.T. Caskey,
M.S. Swanson, and
L.T. Timchenko.
1997.
Altered phosphorylation and intracellular
distribution of a (CUG)n triplet repeat RNA-binding protein in patients
with myotonic dystrophy and in myotonin protein kinase knockout mice.
Proc. Natl. Acad. Sci. USA
94:
13221-13226
|
71. | Roth, M.B.. 1995. Spheres, coiled bodies and nuclear bodies. Curr. Opin. Cell Biol. 7: 325-328 |
72. |
Sehgal, P.B.,
J.E. Darnell, and
I. Tamm.
1976.
The inhibition by DRB (5,6-Dichloro-1-![]() |
73. | Singh, R., J. Valcarcel, and M.R. Green. 1995. Distinct binding specificities and function of higher eukaryotic polypyrimidine tract-binding proteins. Science. 268: 1173-1176 |
74. | Siomi, H., and G. Dreyfuss. 1997. RNA-binding proteins as regulators of gene expression. Curr. Opin. Genet. Dev. 7: 345-353 |
75. | Skinner, P.J., B.T. Koshy, C.J. Cummings, I.A. Klement, and K. Helin. 1997. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 389: 971-974 |
76. | Smith, K.P., K.C. Carter, C.V. Johnson, and J.B. Lawrence. 1995. U2 and U1 snRNA gene loci associate with coiled bodies. J. Cell. Biochem. 59: 473-485 |
77. | Spector, D.L., G. Lark, and S. Huang. 1992. Differences in snRNP localization between transformed and nontransformed cells. Mol. Biol. Cell. 3: 555-569 [Abstract]. |
78. | Spector, D.L., R.D. Goldman, and L.A. Leinwand. 1997. Cells: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2,100 pp. |
79. |
Stripe, F., and
L. Fiume.
1967.
Studies on the pathogenesis of liver necrosis by
![]() ![]() |
80. | Terris, B., V. Baldin, S. Dubois, C. Degott, J.F. Flejou, D. Henin, and A. Dejean. 1995. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55: 1590-1597 [Abstract]. |
81. |
Timchenko, L.T.,
J.W. Miller,
N.A. Timchenko,
D.R. DeVore,
K.V. Datar,
L. Lin,
R. Roberts,
C.T. Caskey, and
M.S. Swanson.
1996.
Identification of a
(CUG)n triplet repeat RNA-binding protein and its expression in myotonic
dystrophy.
Nucleic Acids Res.
24:
4407-4414
|
82. | Wansink, D.G., W. Schul, I. van der Kraan, B. van Steensel, R. van Driel, and L. de Jong. 1993. Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus. J. Cell Biol. 122: 283-293 [Abstract]. |
83. | Weinmann, R., and R.G. Roeder. 1974. Role of DNA-dependent RNA polymerase 3 in the transcription of the tRNA and 5S RNA genes. Proc. Natl. Acad. Sci. USA. 71: 1790-1794 [Abstract]. |
84. | Weinmann, R., H.J. Raskas, and R.G. Roeder. 1975. The transcriptional role of host DNA-dependent RNA polymerases in adenovirus-infected KB cells. Cold Spring Harbor Symp. Quant. Biol. 34: 495-500 . |
85. |
Weis, K.,
S. Rambaud,
C. Lavau,
J. Jansen,
T. Carvalho,
M. Carmo-Fonseca,
A. Lamond, and
A. Dejean.
1994.
Retinoic acid regulates aberrant nuclear localization of PML-RAR![]() |
86. |
Willems, M.,
M. Penman, and
S. Penman.
1969.
The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis.
J.
Cell Biol.
41:
177-187
|
87. | Witherell, G.W., C.S. Schultz-Witherell, and E. Wimmer. 1995. Cis-acting elements of the encephalomyocarditis virus internal ribosomal entry site. Virology. 214: 660-663 |
88. | Wolin, S.L., and J.A. Steitz. 1984. The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc. Natl. Acad. Sci. USA 81: 1996-2000 [Abstract]. |
89. | Xing, Y., and J.B. Lawrence. 1993. Nuclear RNA tracks: structural basis for transcription and splicing. Trends Cell Biol 3: 346-353 . |
90. |
Yuan, Y.,
R. Singh, and
R. Reddy.
1989.
Rat nucleolar 7-2 RNA is homologous
to mouse mitochondrial RNase mitochondrial RNA-processing RNA.
J.
Biol. Chem.
264:
14835-14839
|
91. | Young, S.J., S.M. Royer, P.M. Groves, and J.C. Kinnamon. 1987. Three-dimensional reconstruction from serial micrographs using an IBM PC. J. Electron Microsc. Tech. 6: 207-215 . |
92. |
Zandomeni, R., and
R. Weinmann.
1984.
Inhibitory effect of 5,6-dichloro-1-![]() |
93. |
Zeng, C.,
E. Kim,
S.L. Warren, and
S.M. Berget.
1997.
Dynamic relocation of
transcription and splicing factors dependent upon transcriptional activity.
EMBO (Eur. Mol. Biol. Organ.) J
16:
1401-1412
|
94. | Zhang, G., K.L. Taneja, R.H. Singer, and M.R. Green. 1994. Localization of pre-mRNA splicing in mammalian nuclei. Nature. 372: 809-812 |